Clinical Trials on CMV

Total 1622 results

CNBG-Virogin Biotech (Shanghai) Ltd.
Shulan (Hangzhou) Hospital

Recruiting

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

SARS-CoV-2 Infection

China
Southeast University, China
Hohhot First Hospital, Hohhot, Inner Mongolia, China

Recruiting

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

SARS-CoV-2 Infection

China
Central Hospital, Nancy, France

Not yet recruiting

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains. (Spread-COVID)

SARS-CoV-2 Infection

France
Columbia University
Gilead Sciences

Recruiting

CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2

COVID-19 | SARS CoV 2 Infection

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

CML, Chronic Phase

China
University of L'Aquila

Recruiting

Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment

COVID-19

Italy
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

COVID-19 | Sars-CoV-2 Infection
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Long-term Effects of COVID-19

COVID-19 | SAR-CoV-2

United States
Institut Pasteur
Hopital Lariboisière

Recruiting

Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19 (ETOC)

SARS-CoV-2 Acute Respiratory Disease

France
Mahidol University
Janssen Pharmaceuticals; International Vaccine Institute; National Vaccine Institute...

Recruiting

Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine

SARS-CoV-2 Infection

Thailand
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector

Covid19 | SARS-CoV-2

Belgium
Walvax Biotechnology Co., Ltd.
Abogen Biosciences Co. Ltd.; Yuxi Walvax Biotechnology Co., Ltd.

Recruiting

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

COVID-19 | SARS-CoV-2

Indonesia, Mexico
Bahçeşehir University
The Scientific and Technological Research Council of Turkey; Medipol University

Recruiting

Investigation the Effect of Montelukast in COVID-19

COVID-19 | SARS-CoV-2

Turkey
Halodine LLC

Not yet recruiting

Halodine Nasal Antiseptic in Patients With COVID-19

SARS-CoV-2 Infection
INanoBio Inc.
TMC HealthCare

Recruiting

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Infection

United States
ModernaTX, Inc.

Completed

A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

SARS-CoV-2

Australia
Duke University

Completed

Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling (Snowball)

COVID-19 | SARS-CoV 2

United States
AstraZeneca

Active, not recruiting

A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 (ARTEMIS-C)

COVID-19 | SARS-CoV-2 Infection

United States
WestVac Biopharma Co., Ltd.

Completed

A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)

COVID-19 | SARS-CoV-2 Pneumonia

China
WestVac Biopharma Co., Ltd.

Completed

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

COVID-19 | SARS-CoV-2 Infection

Philippines
Sichuan Huiyang Life Science and Technology Corporation

Active, not recruiting

rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19

COVID-19 | SARS-CoV-2 Infection

Philippines
Johns Hopkins University

Completed

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

SARS-CoV-2 Infection

United States
University of Rostock

Completed

Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19

SARS-CoV-2 Infection

Germany
GlaxoSmithKline
CureVac

Active, not recruiting

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

SARS-CoV-2

Australia, United States
VA Office of Research and Development
Johns Hopkins University

Enrolling by invitation

COVID-19 Observational Research Collaboratory (CORC LTO)

COVID-19 | SARS-CoV-2 Infection

United States
Sinocelltech Ltd.

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

COVID-19 | SARS-CoV-2 Infection
Health Institutes of Turkey

Completed

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Insud Pharma

Terminated

Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50

COVID-19 | SARS-CoV-2

Spain
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

SARS-CoV-2 Infection

China
Novavax

Completed

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

COVID-19 | SARS-CoV-2 Infection

United States, Brazil, South Africa, Germany, Canada, Israel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

SARS-CoV-2 Infection

China
University of Jena
Novartis Pharmaceuticals; Ludwig-Maximilians - University of Munich

Active, not recruiting

Frontline Asciminib Combination in Chronic Phase CML (CMLXI)

Chronic Myeloid Leukemia

Germany
University of Chicago
Rush University Medical Center

Active, not recruiting

Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19

SARS-CoV-2 Infection

United States
Shanghai Zerun Biotechnology Co.,Ltd

Active, not recruiting

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

COVID-19 | SARS-CoV-2 Infection

Mali
Novavax

Completed

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

COVID-19 | SARS-CoV-2 Infection

United Kingdom
Valentin Fuster

Completed

FREEDOM COVID-19 Anticoagulation Strategy (FREEDOM COVID)

COVID-19 | SARS-CoV-2

United States, Colombia, India, Mexico, Brazil
BioNTech SE
Pfizer

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults

COVID-19 | SARS-CoV-2 Infection

Japan
BioNTech SE
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

COVID-19 | SARS-CoV-2 Infection

United States
Nikita Gupta

Completed

COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients (PIIPPI)

COVID-19 | SARS-CoV 2

United States
P & B Group
MediAxe CRO

Terminated

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

SARS-CoV-2 Infection

France
Memo Therapeutics AG

Completed

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

SARS-CoV-2 Infection

Australia
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

SARS-CoV-2 Infection

China
University of Pecs
Hungarian Ministry of Innovation and Technology; HECRIN Consortium

Completed

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

SARS-CoV-2 Infection

Hungary
University of Wisconsin, Madison

Completed

SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding (SHIELD)

COVID-19 | SARS-CoV 2

United States

3

Subscribe